Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cianna Medical, a medical device company, has received two new patents from the US Patent and Trademark Office that are directly related to its Savi multi-catheter brachytherapy device for the treatment of breast cancer.
Subscribe to our email newsletter
The patents represent the first issued for a family of applications focused in brachytherapy, said Cianna.
According to the company, the Savi multi-catheter open architecture design allows for the delivery of patient-specific radiation that minimizes the radiation dose to healthy tissue. For appropriate patients, Savi is an advanced technology that may reduce treatment time to just five days, versus six to eight weeks for traditional radiation therapy.
Jill Anderson, president and CEO of Cianna Medical, said: “These two patents are the first of many we expect to secure through our comprehensive intellectual property portfolio.
“We are well positioned to protect our products and our leadership in the breast brachytherapy market. Strong IP and innovative technology make accelerated partial beast irradiation with Savi a viable therapy for women suffering from breast cancer.”